Several biological properties of lipoproteins are modified by oxidative reactions. Modified lipoproteins are rapidly degraded by macrophages, and this is likely to be a major pathway for the formation of foam cells in the early phases of atherosclerosis. The effect of modification on other aspects of cholesterol homeostasis has, however, received lesser attention. In this study, the influence of copper ion-as well as rat aortic smooth muscle cell-oxidation-modified high density lipoprotein (HDL) on cholesterol biosynthesis in human skin fibroblasts has been investigated. Modified lipoproteins eluted at higher ionic strength than did control HDL on a Mono-Q 5/5 anion-exchange column. However, only copper ion-modified HDLs displayed greater electrophoretic mobility than did control lipoproteins on agarose gel electrophoresis. Both control and modified HDLs decreased cholesterol esterification in fibroblasts. On the other hand, whereas control HDLs were virtually ineffective in modulating cholesterol biosynthesis, modified HDLs had a significant suppressing effect This was observed in normal as well as low density lipoprotein (LDL) receptor-defective fibroblasts, which are unresponsive to the LDL-mediated down regulation of cholesterol synthesis. These results are consistent with the concept that oxidative modification of HDLs drastically alters their effect on cholesterol homeostasis in fibroblasts. The data furthermore suggest the existence of a lipoprotein pathway for cholesterol biosynthesis regulation that is independent of the LDL receptor-mediated pathway. Downregulation of cholesterol biosynthesis would be a new function for oxidatively modified lipoproteins. 2 Whereas much is known about the effect that oxidatively modified lipoproteins have on macrophage cholesterol homeostasis, considerably less information is available about the effects that these altered lipoproteins have on cells that express only the low density lipoprotein (LDL) receptor. In these cells, unlike macrophages, cholesterol metabolism is tightly coordinated through a process involving the specific uptake of LDL, leading to downregulation of both cholesterol biosynthesis and LDL receptor expression. In this way, further LDL uptake is decreased and intracellular accumulation of cholesterol is prevented. As much as 70% of the clearance of the circulating LDL is receptor mediated, and a large part of this process take place in the liver. 4 Peripheral fluid is rather enriched with high density lipoproteins (HDLs).
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Several biological properties of lipoproteins are modified by oxidative reactions. Modified lipoproteins are rapidly degraded by macrophages, and this is likely to be a major pathway for the formation of foam cells in the early phases of atherosclerosis. The effect of modification on other aspects of cholesterol homeostasis has, however, received lesser attention. In this study, the influence of copper ion-as well as rat aortic smooth muscle cell-oxidation-modified high density lipoprotein (HDL) on cholesterol biosynthesis in human skin fibroblasts has been investigated. Modified lipoproteins eluted at higher ionic strength than did control HDL on a Mono-Q 5/5 anion-exchange column. However, only copper ion-modified HDLs displayed greater electrophoretic mobility than did control lipoproteins on agarose gel electrophoresis. Both control and modified HDLs decreased cholesterol esterification in fibroblasts. On the other hand, whereas control HDLs were virtually ineffective in modulating cholesterol biosynthesis, modified HDLs had a significant suppressing effect This was observed in normal as well as low density lipoprotein (LDL) receptor-defective fibroblasts, which are unresponsive to the LDL-mediated down regulation of cholesterol synthesis. These results are consistent with the concept that oxidative modification of HDLs drastically alters their effect on cholesterol homeostasis in fibroblasts. The data furthermore suggest the existence of a lipoprotein pathway for cholesterol biosynthesis regulation that is independent of the LDL receptor-mediated pathway. Downregulation of cholesterol biosynthesis would be a new function for oxidatively modified lipoproteins. macrophages has raised considerable interest and may be a key phenomenon in the conversion of resident monocytes/macrophages of the arterial wall into foam cells, the earliest histological evidence of atherosclerosis.
-
2 Whereas much is known about the effect that oxidatively modified lipoproteins have on macrophage cholesterol homeostasis, considerably less information is available about the effects that these altered lipoproteins have on cells that express only the low density lipoprotein (LDL) receptor. In these cells, unlike macrophages, cholesterol metabolism is tightly coordinated through a process involving the specific uptake of LDL, leading to downregulation of both cholesterol biosynthesis and LDL receptor expression. 3 In this way, further LDL uptake is decreased and intracellular accumulation of cholesterol is prevented. As much as 70% of the clearance of the circulating LDL is receptor mediated, and a large part of this process take place in the liver. 4 Peripheral fluid is rather enriched with high density lipoproteins (HDLs). 5 -6 The functional role of HDL at this site is believed to concern From the Fannitalia Carlo Erba Research Institute, Milan, Italy.
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Received February 19, 1992 ; revision accepted April 14, 1992. reverse cholesterol transport of excess biosynthesized cholesterol by the peripheral tissues to the liver. 7 Unlike LDLs, HDLs do not depress cellular cholesterol biosynthesis. 8 In this communication, results are presented that show that oxidatively modified HDLs are potent suppressors of cellular cholesterol biosynthesis via a pathway that is LDL-receptor independent.
Methods

Lipoproteins
Blood from healthy volunteers was collected in tubes containing Na 2 EDTA (3 mM) as an anticoagulant. As a preservative, gentamicin sulfate (0.005%) and phenylmethylsulfonyl fluoride (1 mM) were added to the plasma, which was stored at 4°C and used for lipoprotein isolation within 36 hours. 9 LDL (d= 1.019-1.063 g/ml) and HDL (^=1.063-1.210 g/ml) were isolated by ultracentrifugation. 10 All of the density solutions used to adjust the flotation density of the lipoproteins contained 1 mM Na 2 EDTA. After isolation, the lipoproteins were dialyzed overnight against 0.15 M potassiumsodium phosphate buffer (PBS), pH 7.4. After they were sterile filtered by passage through a Millex-HA 0.45 -^.m filter, HDL and LDL were stored at 4°C and used within 24 hours.
To induce modifications, HDLs were diluted to a concentration of 1-3 mg cholesterol/ml with PBS and incubated for 24 hours at 37°C in the presence of 50 930
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CuSO 4 . The copper sulfate oxidative challenge was terminated by chromatography of HDL through a PD-10 Sephadex column eluted with PBS. It was established earlier that removal of copper sulfate by this procedure soon after its addition to HDL effectively prevented HDL oxidation by further incubation. Cell-mediated lipoprotein modification was accomplished by incubating HDL (100 /tg cholesterol/ml) with rat aortic smooth muscle cells in serum-free Ham's F-12 medium. Dishes were placed in a humidified-air incubator with 5% CO 2 at 37°C for 24 hours. Copper ion-and cell-modified HDLs were reisolated by ultracentrifugation (d= 1.063-1.210 g/ml), dialyzed against PBS, sterile filtered, and stored at 4°C. Modified lipoproteins were analyzed and added to the skin fibroblast cultures within 24 hours. HDLs that had been incubated at 37°C for 24 hours in dishes without cells were reisolated as described and are henceforth identified as "unmodified HDL." The terms "native LDL" and "native HDL" refer to LDL and HDL preparations that had not been incubated but that were reisolated by ultracentrifugation.
Lipoprotein lipids were extracted from lyophilized lipoprotein preparations in the presence of 0.05% 2,6-di-f-butyl-4-methylphenol as an antioxidant, essentially as described by Kates, 11 by using chloroform/methanol, 2:1 (vol/vol). The lipids were stored in the presence of the antioxidant at 4°C until used.
Lipoprotein Analysis
Lipoprotein protein content was determined according to Lowry et al 12 by using a calibrated bovine serum albumin (BSA) standard from Bio-Rad. Cholesterol (total and unesterified), triglycerides, and choline-containing phospholipids were determined by automated enzymic assays 13 
"
15 on a Coulter CPA Autoanah/zer. Thiobarbituric acid-reactive substances (TBARS) in lipoproteins as a measure of lipid peroxidation were quantified as described by Ohkawa et al 16 and expressed as the malondialdehyde equivalent content in nanomoles per milligram of protein by using an extinction coefficient determined from a malondialdehyde tetramethyl acetal-generated standard curve.
Agarose gel electrophoresis of native and modified lipoproteins was performed on Paragon Lipo-Gel strips from Beckman by using the Beckman electrophoresis apparatus at a constant voltage (100 V) for 30 minutes and following the manufacturer's directions for electrophoretic conditions, gel staining, and destaining.
Fast protein liquid chromatography of lipoproteins was carried out on a Pharmacia apparatus fitted with a Mono-Q 5/5 (anionic exchange) column at a flow rate of 1 ml/min and a back pressure of 2 atm. Optical density of the eluate was recorded continuously at 280 nm. The starting elution buffer was 0.02 M tris(hydroxymethyl)-aminomethane hydrochloride (Tris HC1), pH 7.4. Salt concentration was increased at 5 minutes to 0.2 M with the addition of sodium chloride and reached 0.6 M within 20 minutes by establishing a linear gradient of sodium chloride. Lipoproteins, previously dialyzed against 0.01 M Tris HC1, pH 7.4, were injected at a concentration of 1 mg protein/ml.
Cells
Normal human skin fibroblasts (N-HSFs) were grown from the forearm biopsy of a 25-year-old healthy normolipidemic volunteer. The LDL receptor-defective fibroblasts (FH-HSFs) were purchased from the NIGMS Genetic Mutant Cell Repository and were from a patient with homozygous familial hypercholesterolemia. The cells were grown in a humidified incubator with 5% CO 2 in Dulbecco's minimal essential medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS) and 0.01% streptomycin. For the experiments, cells between the eighth and 15th passage were plated onto 35-mm plastic dishes and used when they reached 90-95% confluence. Before the experiments, the cells were maintained for 24 hours in DMEM supplemented with 5% lipoprotein-deficient serum (LPDS).
Rat aortic smooth muscle cell cultures were grown in DMEM supplemented with 10% FCS and 0.01% streptomycin in humidified air with 5% CO 2 . The cell cultures were used to modify HDL when the former reached the fifth to the eighth passage and 90-95% confluence.
Cellular Lipid Quantification and Cholesteryl Ester Formation Assay
The cell monolayers were washed twice with DMEM and supplemented with 2 ml DMEM containing 0.2% BSA (DMEM-BSA). Lipoproteins were added to the cells at a calculated concentration that was based on their cholesterol content. After 18 hours, [ 14 C]oleate (1 Ci/ml) as a complex with BSA 17 was added. Incubation was continued for an additional 6 hours and terminated by washing the cells three times with 2 ml DMEM-BSA and then twice with 2 ml DMEM while keeping the dishes on ice. The lipids were extracted in situ by pouring 2 ml hexane/isopropanol, 3:2 (vol/vol), over the cells. The dishes were kept at room temperature for 30 minutes, and after removal of the solvent, the procedure was repeated. The combined extracts were evaporated under nitrogen and the lipids redissolved in hexane. Aliquots of the extract were taken for cholesterol and cholesteryl ester determination by the fluorometric procedure of Gamble et al. 18 Another aliquot was applied onto a silica-gel 60 F254 plastic sheet from Merck and chromatographed by using heptane/ethyl ether/acetic acid, 90:30:1 (vol/vol/vol), as the developing system. Phospholipid, cholesterol, triglyceride, and cholesteryl ester bands were positively identified by comparison with egg phosphatidylcholine, recrystallized cholesterol, tripalmitin, and cholesteryl oleate standards. The lipid bands were enhanced with 8% phosphomolybdic acid, cut out, and finally counted in a Packard Tricarb 1900 CA beta counter with automatic correction for quenching. The radioactivity recovered in the cholesteryl ester band was regarded as a direct measure of the cellular cholesteryl ester synthetic activity. The remaining adherent cells were dissolved in 0.1 M NaOH overnight at room temperature. Cellular proteins were determined according to Lowry et al 12 by using a calibrated BSA standard.
Cellular Lipid Biosynthesis
The cells were washed two times with DMEM and then received DMEM-BSA as for the previous experiments. The lipoproteins were supplemented to the cells based on cholesterol content of the previous 2 hours before addition of [ M C]acetate (2 jiCi/ml). The lipopro- tein lipids (dissolved in ethanol) were added to the cells so that each culture dish received 10 jul of the lipid solution per milliliter of medium. Control dishes received 10 /xl/ml ethanol. The incubations with lipoproteins and lipoprotein lipids were terminated after 6 hours. The cell monolayers were washed three times with DMEM-BSA and then twice with DMEM while the dishes were kept on ice. The cellular lipids were extracted and separated by thin-layer chromatography as detailed for the cholesterol esterification experiments. The bands were cut out and counted. Radioactivity associated with the cholesterol band was regarded as a direct index of the overall activity of the cholesterol biosynthetic pathway. Thus, no correction was introduced for the fact that some cholesterol precursors and metabolites might comigrate with authentic cholesterol in this system. However, cholesterol is the major sterol synthesized by fibroblasts. 19 The cellular protein content was measured as described.
Assay of Cellular HMG-CoA Reductase Activity
Cells grown in 100-mm dishes were washed with DMEM before receiving DMEM-BSA. After addition of lipoprotein, the incubation was continued for 8 hours. Cellular 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity was assayed and determined as described by Goldstein et al. 17 Briefly, the cells were harvested by scraping from the dishes and were lysed at room temperature by addition of 0.1 ml 50 mM phosphate solution containing 0.25% 10 Brij 96, 5 mM dithiothreitol, 5 mM Na 2 EDTA, and 0.2 M KC1, pH 7.4. The resulting detergent-solubilized suspension was centrifuged for 1 minute at 12,000 rpm in a Beckman microfuge, and an aliquot of the supernatant was assayed for HMG-CoA reductase activity by using [ 14 C]HMG-CoA. The formed, labeled mevalonate was lactonized by incubation at 37°C for 30 minutes, adsorbed over disodium sulfate, and extracted with diethyl ether. The mevalonolactone was separated by thin-layer chromatography, and the band corresponding to the product was cut out and counted.
Results
TBARS content of native and unmodified HDL was 4.2±1.2 and 4.3±1.3 nmol/mg protein (n=3), respectively. Incubation with copper ions or rat aortic smooth muscle cells enhanced the TBARS content of HDL to 56.3±8.9 or 18.5±3.9 nmol/mg (n=3), respectively. Control, copper ion-modified, and smooth muscle cellmodified HDLs were further analyzed by fast protein liquid chromatography using a Mono-Q 5/5 anion-exchange column (Figure 1 ). The elution of oxidized HDL was delayed compared with that of both native and unmodified HDL, indicating that modified HDL had gained a more negative charge. The changes brought about by incubation of HDL with 50 nM CuSO 4 appeared more extensive than those produced by smooth muscle cells. This was also evidenced by the migration Preliminary experiments showed that modified lipoproteins were not toxic to the fibroblasts when the former were added to the cultures up to a concentration of 250 ^.g cholesterol/ml medium. Specifically, modified lipoproteins did not affect cell adherence to the plates, and cell morphology at the light-microscopic level was normal. In addition, cell protein recovery from the plates was constant, independent of the amount of lipoprotein added. Incubation of native, copper ionmodified, and cell-modified HDL over a concentration range of 10-50 jtg cholesterol/ml medium led to a noticeable reduction of intracellular cholesteryl esters. Results are presented in Table 2 24 .5% in FH-HSFs. Higher concentrations of copper ion-modified HDL were increasingly active. In N-HSFs, the effect of 30 /xg/ml copper ion-modified HDL was comparable to that achieved by 100 jig/ml native LDL. In FH-HSFs, which are insensitive to the cholesterol biosynthesis downregulation of LDL, copper ion-modified HDLs were as effective as they were in N-HSFs. The effect of cell-modified HDL was similar to that of copper ion-modified HDL, although higher lipoprotein concentrations were necessary to achieve comparable effects. Chloroform/methanol lipid extracts of both copper ion-and cell-modified HDL were as active (on the basis of cholesterol added) as the intact modified lipoprotein. The effect brought about by copper ion-and cell-modified HDL on cholesterol biosynthesis was confirmed by investigating lipoprotein activity in the fibroblast's HMG-CoA reductase. Results are presented in Table 4 .
Discussion
Oxidative modification has important consequences for the interaction of lipoproteins with cells. Oxidatrvely modified LDLs interfere with several cell functions, alter organ responses to pharmacological stimuli, are •As lipoprotein cholesterol. V<0.05 vs. "None" group by t test. cytotoxic, and increase the cholesterol content of macrophages 20 -22 (also see the reviews in References 1 and 2). Other aspects of the effect that oxidatively modified lipoproteins have on cellular cholesterol homeostasis have received considerably less attention. The effect on lipidogenesis is an example. In the present study, we found that unlike native circulating HDL, oxidized HDLs potently inhibited cholesterol biosynthesis in fibroblasts. This effect was also evident in cells unresponsive to the LDL-mediated suppression of cholesterol biosynthesis. This suggests that the cholesterol biosynthesis downregulation mediated by oxidized HDL is independent of a functional LDL receptor pathway. Previously, we have shown that oxidatively modified HDLs inhibit cholesterol biosynthesis in an established line of macrophages, 23 supporting the concept that oxidatively modified HDLs are efficacious in different cell types.
The effect of copper ion-oxidized HDL on the fibroblast's cholesterol biosynthesis was mimicked, albeit less intensively, by HDLs that had been modified by incubation with rat aortic smooth muscle cells. Although the cell-mediated alteration of HDL could not be detected by examining the electrophoretic mobility of these lipoproteins on agarose gels, both the enhancement of the TBARS content and the delay in elution from the Mono-Q 5/5 column support the idea that HDL had undergone oxidative modification. A crucial event in both cell-and metal-induced modification of LDL is peroxidation of the lipoprotein lipids, 24 -27 with the formation of fatty acid endoperoxides 28 and oxysterols. 29 The effect of oxysterols on cholesterol homeostasis is particularly well recognized. 30 Some oxidized products of cholesterol completely mimic the effect elicited by the receptor-mediated uptake of LDL, i.e., they cause cholesterol biosynthesis suppression at the mevalonate formation site, activate cholesterol esterification, and decrease LDL receptor expression. 3 Other oxysterols have different effects on these processes. For example, it has been shown that oxysterols that are formed during copper ion-mediated oxidation of LDL are responsible for the suppression of cholesterol esterification that is observed in macrophages exposed to oxidized lipoproteins. 31 Akin to LDL, oxidation of HDL has perhaps engendered the formation of bioactive lipid peroxides. In fact, the lipid extracts of both cell-and copper ion-oxidized HDL suppressed cholesterol biosynthesis like that produced by the intact oxidized lipoproteins.
In this study, native and oxidized HDLs decreased [ H C]oleate incorporation into cholesteryl esters. Whether the ability of copper ion-and cell-modified HDL to decrease cholesterol esterification is due to specific oxysterols formed, or alternatively, whether the capability of native HDL to suppress fibroblast cho- HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; N-LDL, native low density lipoprotein; N-HDL, native high density lipoprotein; U-HDL, unmodified HDL; Cu-HDL, copper ion-modified HDL; SMC-HDL, rat aortic smooth muscle cell-modified HDL (see text for details). N-HSF, skin fibroblasts from a normolipidemic subject; FH-HSF, skin fibroblasts from a familial hypcrcholesterolemia homozygous patient. All values are mean±SD from three experiments, except for N-HDL, which is from four experiments.
*As lipoprotein cholesterol.
lesteryl ester formation has not been significantly affected by oxidation, cannot be presently established. It is noteworthy that incubation with modified HDL also decreased fibroblast cholesteryl ester content. This finding suggests that the ability of native HDL to promote cellular cholesterol efflux 32 had been maintained by modified HDL. Unlike apolipoprotein B in LDL, 33 apolipoprotein A-I in HDL does not fragment on oxidation, 34 and its lipid-organizing properties may not be critically affected by oxidation.
The effect of modified lipoproteins appeared to be the same (on the basis of lipoprotein cholesterol added) as that of LDLs, which suppress cholesterol biosynthesis in N-HSFs via the LDL receptor pathway. 3 Clearly, the oxidative modification of HDL is changing an otherwise inactive lipoprotein species into a potent cholesterol biosynthesis suppressor. The functional significance of this finding can only be speculative at present. The ability of rat aortic smooth muscle cells to modify HDL raises the possibility that, as is thought for LDL, 35 oxidation of HDL might also occur in vivo. Given the large amount of circulating antioxidants, however, there is considerable skepticism as to whether lipoprotein oxidation would be a significant process in the bloodstream. More likely, oxidation is confined to sites where lipoprotein turnover is slowed by diffusional barriers and where HDL may be acted on by the resident cell population. At these sites, formed, oxidized HDLs may act as autacoids to modulate cholesterol biosynthesis. Perhaps while native HDLs are active in the reverse cholesterol transport mechanism, 6 -7 oxidized HDLs may prevent the upregulation of cholesterol biosynthesis caused by cholesterol efflux from the cell. 32 In this sense, oxidized HDL would back up the LDL-mediated downregulation of cholesterol biosynthesis. This backup mechanism may be of particular significance in patients with a defective LDL receptor mechanism. Clearly, further studies will be necessary to corroborate these hypotheses. Akin to the situation with cell-modified HDL, we found that oxidatively modified LDL also can decrease cholesterol biosynthesis in normal as well as LDL receptor-deficient cells (G. Ghiselli et al, unpublished observations). Downregulation of cholesterol biosynthesis may therefore be a common feature of oxidized lipoproteins and in this sense would be a new, previously poorly recognized property of oxidized lipoproteins.
